Ocugen
Price & Volume
Stats
See moreOpen | $1.62 |
Previous Close | $1.63 |
Day Range | $1.62-$1.74 |
52W Range | $0.51-$1.78 |
Market Cap | $509M |
Shares Short | 54M |
Financials
See moreRevenue (12 Mos) | $4.7M |
Revenue Growth (YoY) | 20.3% |
Gross Profit (12 Mos) | -$29.5M |
Diluted EPS | -$0.21 |
News
See moreYahoo Finance • 16 days ago
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
Yahoo Finance • 29 days ago
Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025
Yahoo Finance • 2 months ago
Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST—Modifier Gene Therapy for Stargardt Disease
Yahoo Finance • 2 months ago
Ocugen, Inc. Announces Closing of $20 Million Registered Direct Offering of Common Stock and Warrants
About
CEO | Dr. Shankar Musunuri M.B.A., Ph.D. |
Address | 11 Great Valley Parkway, Malvern, PA, United States, 19355 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 95 |
